ArticleProceedings of the National Academy of Sciences of the United States of America2026
Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modulation of DNA Damage by Epstein-Barr Virus (EBV).Viruses · 2026Review
- A host-centric morphological profiling approach to identify repurposed antiviral drugs.iScience · 2026Article
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Epstein-Barr virus (EBV) lytic infection contributes to oncogenesis and autoimmunity and depends on subversion of host DNA damage responses (DDR). We used high-content screening (HCS) to systematically capture single-cell morphologic profiles and pseudotemporal dynamics of EBV reactivation and DDR across common B cell models and lytic induction treatments. We generated an atlas (>850,000 cells) of spatiotemporally distinct phenotypes of immediate-early and late lytic proteins, viral and cellular DNA replication, and double-stranded break (DSB) DDR factors. Cell segmentation, feature quantification, and clustering identified treatment- and model-dependent cell responses and lytic induction. Lytic and latent cells showed distinct genotoxin-induced DDR profiles, and lytic protein localization varied by pharmacologic and physiologic stimuli. Pseudotime trajectories revealed viral replication compartment (VRC) nucleation and expansion alongside concomitant DDR localization. The early DDR marker γH2AX was depleted from VRCs but widespread across host chromatin throughout reactivation. Surprisingly, the lytic-essential late DDR protein 53BP1 was present prior to viral genome replication but subsequently undetected in VRCs and host chromatin, indicating spatial and kinetic DDR dysregulation during EBV reactivation. These data support a model wherein EBV transiently employs host DSB DDR mediators to initiate genome replication while host-targeted DDR is initiated but impaired. We further show biological generalizability and utility of our method across microscope systems. HCS paired with morphologic pseudotime analysis thus provides a powerful approach to recover single-cell host-virus dynamics from snapshot samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.